Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
32.62
+0.13 (0.40%)
At close: May 12, 2025, 4:00 PM
32.25
-0.37 (-1.13%)
After-hours: May 12, 2025, 7:15 PM EDT
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $233.82 million as of May 12, 2025. Its market cap has increased by 2,023.71% in one year.
Market Cap
233.82M
Enterprise Value
192.60M
1-Year Change
2,023.71%
Ranking
Category
Stock Price
$32.62
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $233.82M, an increase of 459.60%. That is a compound annual growth rate of 49.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 228.60M | -8.79% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |